Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 2008 Dec 30;47(3):852–854. doi: 10.1128/JCM.01196-08

Necrotizing Fasciitis Caused by Haemophilus influenzae Type b in an Elderly Patient

Takashi Saito 1,*, Hiromi Matsunaga 2, Yumi Matsumura 2, Hajime Segawa 3, Shunji Takakura 1, Miki Nagao 1, Yoshitsugu Iinuma 1, Yoshiki Miyachi 2, Satoshi Ichiyama 1
PMCID: PMC2650905  PMID: 19116357

Abstract

Necrotizing fasciitis caused by Haemophilus influenzae type b is a rare infection of the skin and soft tissues. The only previously reported case involved a healthy infant. We report herein the case of an 81-year-old Japanese woman with diabetes mellitus who developed necrotizing fasciitis caused by H. influenzae type b.

CASE REPORT

An 81-year-old Japanese woman presented to the outpatient dermatology department at Kyoto University Hospital with painful swelling of the left leg. She had a history of type II diabetes mellitus and had not previously been vaccinated against Haemophilus influenzae type b. Physical examination revealed swelling, erythema, purpura of the left lower extremity, and hemorrhagic bullous lesions of the left dorsum (Fig. 1). Swelling and erythema spread rapidly to the left lower limb, and she became unconscious 1 h after presentation. The patient was therefore transferred to the intensive care unit.

FIG. 1.

FIG. 1.

Hemorrhagic bullae on the edematous foot.

Examination revealed the following: temperature, 36.4°C; heart rate, 132 beats/min; respiratory rate, 24 breaths/min; blood pressure, 107/88 mmHg. Laboratory examinations showed the following: white blood cell count, 3.5 ×109 cells/liter with 3% segmented cells, 38% band cells, 22% metamyelocytes, 21% myelocytes, 15% lymphocytes, and 1% eosinophils; platelet count, 34,000/liter; prothrombin time, 18.0 s; activated partial thromboplastin time, 42.7 s; fibrinogen, 839 mg/dl; fibrin degradation product, 2.4 μg/ml; aspartate aminotransferase level, 23 IU/liter; creatinine level, 4.7 mg/dl; C-reactive protein level, 28.1 mg/dl. Blood gas analysis under room air revealed the following: pH, 7.188; pCO2, 31.6 mmHg; pO2, 70.7 mmHg; HCO3, 11.8 mmol/liter; base excess, −15.2 mmol/liter.

Two sets of blood cultures, with BacT/Alert aerobic (FA) and anaerobic (FN) bottles (bioMérieux, Marcy l'Etoile, France), were performed. Bedside biopsy material from the affected area of the left lower extremity yielded gram-negative rods with polymorphonuclear leukocytes on Gram staining. Combination antibiotic therapy including meropenem (1 g/day divided into two doses) and minocycline (400 mg/day divided into two doses) adjusted to renal dysfunction was empirically started. Extensive debridement was performed 7 h after presentation. The subcutis, fascia, and muscles were totally necrotic. As complications of acute renal failure were also present, continuous hemodialysis was initiated.

On hospitalization day 2, all blood cultures obtained on admission revealed gram-negative rods on Gram staining. On hospitalization day 3, H. influenzae was isolated with the RapID NH system (Remel, Lenexa, KS) from all blood cultures and surgical specimens of bedside biopsy material and debrided tissue. Antibiotic susceptibility tests performed by the microdilution method with an MIC2000 system (Nagase, Tokyo, Japan) revealed the H. influenzae isolate to be susceptible to ampicillin (MIC, 0.5 μg/ml), cefotaxime (MIC, 0.25 μg/ml), clarithromycin (MIC, ≤0.25 μg/ml), meropenem (MIC, ≤0.12 μg/ml), and levofloxacin (MIC, ≤0.25 μg/ml) according to the criteria for interpretation defined by the Clinical and Laboratory Standards Institute (9). No H. influenzae isolates produced β-lactamase according to examination by the nitrocefin disk method (Cefinase; Becton Dickinson Microbiology Systems, Tokyo, Japan). A type b isolate was confirmed by using H. influenzae antisera a to f (Denka Seiken, Tokyo, Japan).

Necrotizing fasciitis was confirmed histopathologically with debrided tissue revealing necrosis from dermis to fascium, along with capillary thrombosis and polymorphonuclear leukocytic infiltration (Fig. 2). The patient was switched to cefotaxime (4 g/day divided into two doses) adjusted to renal dysfunction according to in vitro results of antibiotic susceptibility testing. The patient had received intravenous cefotaxime for a total of 28 days until 31 days after presentation. Extensive autografting was performed to close the wound 71 days after admission. The patient recovered fully and was discharged from the hospital 135 days after admission.

FIG. 2.

FIG. 2.

Histopathological appearance of debrided tissue.

Necrotizing fasciitis is an infectious process that progressively destroys the subcutaneous fascia and fat while relatively sparing the underlying muscle (14). Mixed aerobic and anaerobic microorganisms or group A streptococci have generally been considered responsible for necrotizing fasciitis (13), and the condition is associated with substantial morbidity and mortality in the absence of aggressive surgical and antibiotic therapy (7). A review of the English literature revealed seven case reports of Haemophilus-associated necrotizing fasciitis (1, 3-5, 8, 11, 12). Among these cases of necrotizing fasciitis associated with H. influenzae, the first case was of lower limb necrotizing fasciitis caused by H. influenzae type b in a 13-month-old infant (3). The second case was caused by unencapsulated H. influenzae in a 45-year-old patient with insulin-dependent diabetes mellitus who developed necrotizing fasciitis in the right gluteal region and lateral thigh (12). In the third case, fatal lower limb necrotizing fasciitis was caused by H. influenzae type f in a 65-year-old patient with a history of hypertension, gout, and excessive alcohol consumption (8). The fourth case occurred in a 79-year-old man with non-insulin-dependent diabetes, with craniofacial necrotizing fasciitis occurring secondary to maxillary sinusitis from which H. influenzae (type unknown) was isolated in association with group A streptococci, Staphylococcus aureus, and Streptococcus pyogenes (11). The fifth case occurred in a 19-month-old infant with necrotizing fasciitis involving the parapharyngeal space, from which nontypeable H. influenzae was isolated in association with S. aureus, Bacteroides fragilis, and Peptostreptococcus species (1). In the sixth case, necrotizing fasciitis was associated with H. aphrophilus in a 35-year-old patient; it was caused by intravenous injection of a dissolved methylphenidate hydrochloride tablet (5). The final case involved cervical necrotizing fasciitis caused by H. aphrophilus in a 5-month-old infant (4). Necrotizing fasciitis caused by H. influenzae type b thus appears rare. The present case thus represents the first case of adult necrotizing fasciitis caused by H. influenzae type b.

In Japan, H. influenzae type b vaccination is not conducted routinely in childhood. The widespread use of effective conjugate vaccines has substantially decreased infections with H. influenzae type b (2, 10). Conversely, the incidence of invasive H. influenzae disease among persons over 65 years old and invasive nontypeable H. influenzae disease increased from 1996 to 2004 (6). The frequency of cases of H. influenzae type f involving necrotizing fasciitis has remained almost unchanged during this period (6). Whether necrotizing fasciitis caused by H. influenzae is becoming more common is therefore unclear.

Invasive H. influenzae disease has occurred in the extreme ages of life in patients with predisposing conditions such as an age of >65 years and diabetes mellitus (7). Diabetes mellitus is a clinical characteristic that may facilitate the development of necrotizing fasciitis (13). Our patient displayed predisposing factors such as old age (81 years), diabetes mellitus, and no vaccination against H. influenzae type b, allowing the development of necrotizing fasciitis caused by H. influenzae type b.

We reported the case of an 81-year-old Japanese woman with diabetes mellitus who developed necrotizing fasciitis caused by H. influenzae type b in which extensive debridement and antibiotic therapy were effective. Physicians should consider that invasive H. influenzae type b disease, including necrotizing fasciitis, can occur even in elderly patients.

Footnotes

Published ahead of print on 30 December 2008.

REFERENCES

  • 1.Bush, J. K., L. B. Givner, S. H. Whitaker, D. C. Anderson, and A. K. Percy. 1984. Necrotizing fasciitis of the parapharyngeal space with carotid artery occlusion and acute hemiplegia. Pediatrics 73343-347. [PubMed] [Google Scholar]
  • 2.Campos, J., M. Hernando, F. Román, M. Pérez-Vázquez, B. Aracil, J. Oteo, E. Lázaro, F. de Abajo, and the Group of Invasive Haemophilus Infections of the Autonomous Community of Madrid, Spain. 2004. Analysis of invasive Haemophilus influenzae infections after extensive vaccination against H. influenzae type b. J. Clin. Microbiol. 42524-529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Collette, C. J., D. Southerland, and C. J. Corrall. 1987. Necrotizing fasciitis associated with Haemophilus influenzae type b. Am. J. Dis. Child. 1411146-1148. [DOI] [PubMed] [Google Scholar]
  • 4.Cordeiro, A. M., A. Bousso, I. de Cassia, O. F. Fernandes, J. C. Fernandes, F. M. Elias, W. A. Jorge, B. Ejzenberg, and Y. Okay. 1997. Cervical necrotizing fasciitis in an infant caused by Haemophilus non influenzae. Infection 25383-384. [DOI] [PubMed] [Google Scholar]
  • 5.Crawford, S. A., J. A. Evans, and G. E. Crawford. 1978. Necrotizing fasciitis associated with Haemophilus aphrophilus. Report of a case. Arch. Intern. Med. 1381714-1715. [PubMed] [Google Scholar]
  • 6.Dworkin, M. S., L. Park, and S. M. Borchardt. 2007. The changing epidemiology of invasive Haemophilus influenzae disease, especially in persons ≥65 years old. Clin. Infect. Dis. 44810-816. [DOI] [PubMed] [Google Scholar]
  • 7.Green, R. J., D. C. Dafoe, and T. A. Raffin. 1996. Necrotizing fasciitis. Chest 110219-229. [DOI] [PubMed] [Google Scholar]
  • 8.McLellan, E., K. Suvarna, and R. Townsend. 2008. Fatal necrotizing fasciitis caused by Haemophilus influenzae serotype f. J. Med. Microbiol. 57249-251. [DOI] [PubMed] [Google Scholar]
  • 9.National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial susceptibility testing; twelfth informational supplement. M100-S12. National Committee for Clinical Laboratory Standards, Wayne, PA.
  • 10.Peltola, H. 2000. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin. Microbiol. Rev. 13302-317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Raboso, E., M. T. Llavero, A. Rosell, and A. Martinez-Vidal. 1998. Craniofacial necrotizing fasciitis secondary to sinusitis. J. Laryngol. Otol. 112371-372. [DOI] [PubMed] [Google Scholar]
  • 12.Stumvoll, M., and A. Fritsche. 1997. Necrotizing fasciitis caused by unencapsulated Haemophilus influenzae. Clin. Infect. Dis. 25327. [DOI] [PubMed] [Google Scholar]
  • 13.Swartz, N. M., and M. S. Pasternack. 2005. Cellulitis and subcutaneous tissue infections, p. 1172-1194. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Churchill Livingstone, Philadelphia, PA.
  • 14.Wilhelm, M. R., and R. S. Edson. 2001. Skin and soft-tissue infections, p. 177-190. In W. R. Wilson and M. A. Sande (ed.), Current diagnosis & treatment in infectious diseases. McGraw-Hill, New York, NY.

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES